308 related articles for article (PubMed ID: 30060554)
1. Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases.
van der Does AM; Amatngalim GD; Keijser B; Hiemstra PS; Villenave R
Vaccines (Basel); 2018 Jul; 6(3):. PubMed ID: 30060554
[TBL] [Abstract][Full Text] [Related]
2. Microbiota abnormalities in inflammatory airway diseases - Potential for therapy.
Gollwitzer ES; Marsland BJ
Pharmacol Ther; 2014 Jan; 141(1):32-9. PubMed ID: 23969226
[TBL] [Abstract][Full Text] [Related]
3. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
[TBL] [Abstract][Full Text] [Related]
4. Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected.
Cheng J; Zhou L; Wang H
Front Cell Infect Microbiol; 2024; 14():1296295. PubMed ID: 38371298
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota and Lung Injury.
Tan JY; Tang YC; Huang J
Adv Exp Med Biol; 2020; 1238():55-72. PubMed ID: 32323180
[TBL] [Abstract][Full Text] [Related]
6. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
7. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of Microbiota Dysbiosis in Chronic Rhinosinusitis: Potential Clinical Implications and Microbial Community Mechanisms Contributing to Sinonasal Inflammation.
Lee K; Pletcher SD; Lynch SV; Goldberg AN; Cope EK
Front Cell Infect Microbiol; 2018; 8():168. PubMed ID: 29876323
[TBL] [Abstract][Full Text] [Related]
9. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
10. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
Peterson CT; Sharma V; Elmén L; Peterson SN
Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
12. Host-Microbe Interactions in Airway Disease: toward Disease Mechanisms and Novel Therapeutic Strategies.
Cope EK
mSystems; 2018; 3(2):. PubMed ID: 29556535
[TBL] [Abstract][Full Text] [Related]
13. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases.
Dumas A; Bernard L; Poquet Y; Lugo-Villarino G; Neyrolles O
Cell Microbiol; 2018 Dec; 20(12):e12966. PubMed ID: 30329198
[TBL] [Abstract][Full Text] [Related]
14. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
[TBL] [Abstract][Full Text] [Related]
15. The possible mechanisms of the human microbiome in allergic diseases.
Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
[TBL] [Abstract][Full Text] [Related]
16. The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases.
Zhang D; Li S; Wang N; Tan HY; Zhang Z; Feng Y
Front Microbiol; 2020; 11():301. PubMed ID: 32158441
[TBL] [Abstract][Full Text] [Related]
17. Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection.
Ouyang J; Isnard S; Lin J; Fombuena B; Peng X; Nair Parvathy S; Chen Y; Silverman MS; Routy JP
Front Med (Lausanne); 2020; 7():421. PubMed ID: 32850913
[TBL] [Abstract][Full Text] [Related]
18. The immunology of host defence peptides: beyond antimicrobial activity.
Hancock RE; Haney EF; Gill EE
Nat Rev Immunol; 2016 May; 16(5):321-34. PubMed ID: 27087664
[TBL] [Abstract][Full Text] [Related]
19. Impact of micro-environmental changes on respiratory tract infections with intracellular bacteria.
Shima K; Coopmeiners J; Graspeuntner S; Dalhoff K; Rupp J
FEBS Lett; 2016 Nov; 590(21):3887-3904. PubMed ID: 27509029
[TBL] [Abstract][Full Text] [Related]
20. Lupus: The microbiome angle.
Yacoub R; Jacob A; Wlaschin J; McGregor M; Quigg RJ; Alexander JJ
Immunobiology; 2018; 223(6-7):460-465. PubMed ID: 29478734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
